2017
DOI: 10.1007/s11701-017-0762-5
|View full text |Cite
|
Sign up to set email alerts
|

Transoral robotic surgery for oncocytic ductal cyst of hypopharynx: a lesion with a high probability of recurrence

Abstract: Hypopharyngeal cysts are very uncommon pathology. They are presented in adult people over 60 years. Although oncocytic cysts are benign tumors, an incomplete resection causes recurrence. The symptoms are not specific, but the more frequent are dyspnea and foreign body sensation upon swallowing. Diagnosis usually is under general anesthesia during intubation. A flexible fiberoptic laryngoscopy could be insufficient; the trumpet maneuver during this examination can reveled occult cysts. To perform a total resect… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 13 publications
0
2
0
Order By: Relevance
“…Despite anatomical difficulties, the hypopharynx can be approached by robotic surgery. The piriform sinus is the most described site of benign tumours and, in this way, parathyroid adenomas, fibromas, oncocytic ductal cysts and lipomas have been reported to be removed using the TORS technique in this area [19][20][21][22]. In one case, a robotic lysis of epiglottis synechiae was performed in a patient with an unusual presentation of pemphigus vulgaris [23].…”
Section: Hypopharynxmentioning
confidence: 99%
“…Despite anatomical difficulties, the hypopharynx can be approached by robotic surgery. The piriform sinus is the most described site of benign tumours and, in this way, parathyroid adenomas, fibromas, oncocytic ductal cysts and lipomas have been reported to be removed using the TORS technique in this area [19][20][21][22]. In one case, a robotic lysis of epiglottis synechiae was performed in a patient with an unusual presentation of pemphigus vulgaris [23].…”
Section: Hypopharynxmentioning
confidence: 99%
“…TORS was first developed between 2004 and 2005 by Weinstein and O'Malley and approved by the Federal Drug Administration (FDA) in 2009 [6]. In Colombia, the first two TORS were performed for a benign pathology in 2013 and reported in 2018 by Cadena et al [7,8]. In this country, 26 patients have been treated with TORS; 11 of them had benign pathology, 14 oropharyngeal, and one supraglottic cancer.…”
Section: Introductionmentioning
confidence: 99%